Live feed
Filing
SC 13G
SC 13G0000902664-24-005789·Inhibikase Therapeutics, Inc.
Schedule 13G ownership disclosure
Inhibikase Therapeutics Inc
Security class unavailable · CUSIP: 45719W205
Event date: 2024-10-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 625,000
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-005789
- Form type
- SC 13G
- Filer
- Inhibikase Therapeutics, Inc.
- CIK
- CIK 1750149
- Filed
- Oct 10, 2024
- Reporting period
- Oct 09, 2024
- Description
- Schedule 13G beneficial ownership